Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in ...

Three critically ill patients treated with procizumab experience a full reversal of cardiogenic shock in 48 hours.

Cite this: Monoclonal Antibodies Make Promising Headway in Sjögren Disease Treatment - Medscape - August 05, 2024. Comments Commenting is limited to medical professionals.

Monoclonal antibodies are a type of synthetic, human-made, antibody. They work similarly to antibodies that the body naturally produces, binding only to specific antigens.

Notably, monoclonal antibodies that target highly conserved regions of the spike, such as the S2 region, or anti-ACE2 antibodies we have previously discussed could be possible combination options.

Monoclonal antibodies have been transformative for treatment of multiple oncologic, rheumatologic, and infectious diseases. Promising trials of these agents for COVID-19 have led to emergency use ...